Relay Therapeutics, Inc. announced that it has entered into a securities purchase agreement to issue 2,500,000 shares at a price of $12 per share for the gross proceeds of $30 million on January 8, 2024. The transaction will include participation from new investor, Nextech. The transaction is expected to close on January 10, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.24 USD | +6.19% | +29.56% | -25.16% |
Jun. 12 | Transcript : Relay Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:40 AM | |
Jun. 06 | Transcript : Relay Therapeutics, Inc. - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.16% | 1.09B | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- RLAY Stock
- News Relay Therapeutics, Inc.
- Relay Therapeutics, Inc. announced that it expects to receive $30 million in funding